IL4 and asthma: Conde and co-workers showed that immunizing mice with IL-4 or IL-13 conjugated to a mutant, nontoxic diphtheria toxin elicited persistent neutralizing antibodies that greatly diminished asthma-like symptoms in a mouse model of allergic airway disease [44].